Jefferies Maintains Buy on Progyny, Lowers Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Glen Santangelo maintains a Buy rating on Progyny (NASDAQ:PGNY) but lowers the price target from $31 to $24.

September 19, 2024 | 6:38 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Jefferies analyst Glen Santangelo maintains a Buy rating on Progyny but lowers the price target from $31 to $24, indicating a more cautious outlook.
The maintained Buy rating suggests continued confidence in Progyny's potential, but the lowered price target reflects a more cautious outlook, possibly due to market conditions or company performance. This mixed signal may lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100